DIAMOND THERAPEUTICS

diamond-therapeutics-logo

Diamond Therapeutics is a psychedelic drug development company based in Toronto. Our mission is to develop new and better therapies for mental health conditions by unlocking the promise of psychedelic compounds. Diamond is focused on sub-perceptual, non-hallucinogenic treatments that hold potential for use across a broad patient cohort โ€” maximizing the positive impact better drugs can have on the global mental health crisis.

#SimilarOrganizations #People #Financial #Website #More

DIAMOND THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Life Science Medical Therapeutics

Founded:
2018-01-01

Address:
Toronto, Ontario, Canada

Country:
Canada

Website Url:
http://www.diamondthera.com

Total Employee:
1+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
0

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Font Awesome Euro Google Apps For Business


Similar Organizations

biohuntress-therapeutics-logo

BioHuntress Therapeutics

BioHuntress Therapeutics is a nature-inspired, scientifically validated, patent-protected drug development platform.

blade-therapeutics-logo

Blade Therapeutics

Blade Therapeutics is a discovery stage drug development company.

pace-analytical-services-logo

Pace Analytical Services

Pace Analytical is a leader in integrated drug development.


Current Advisors List

jamie-tyler_image

Jamie Tyler Scientific Advisor @ Diamond Therapeutics
Advisor
2019-01-01

not_available_image

Richard Boadway Lead independent board member @ Diamond Therapeutics
Board_member

Current Employees Featured

judith-blumstock_image

Judith Blumstock
Judith Blumstock CEO and Founder @ Diamond Therapeutics
CEO and Founder
2018-01-01

not_available_image

David Brown
David Brown Vice president, pharmaceutical development. @ Diamond Therapeutics
Vice president, pharmaceutical development.

Founder


judith-blumstock_image

Judith Blumstock

Investors List

ontario-brain-institute_image

Ontario Brain Institute

Ontario Brain Institute investment in Venture Round - Diamond Therapeutics

Official Site Inspections

http://www.diamondthera.com Semrush global rank: 3.51 M Semrush visits lastest month: 4.21 K

  • Host name: 198.185.159.145
  • IP address: 198.185.159.145
  • Location: New York United States
  • Latitude: 40.7157
  • Longitude: -74
  • Metro Code: 501
  • Timezone: America/New_York
  • Postal: 10013

Loading ...

More informations about "Diamond Therapeutics"

Diamond Therapeutics

Diamond Therapeutics is a psychedelic pharmaceutical company. We're developing safe, FDA, EMA and Health Canada approved therapies for neuropsychiatric conditions, starting with sub-perceptual psilocybin-based โ€ฆSee details»

Diamond Therapeutics - Crunchbase Company Profile โ€ฆ

Diamond Therapeutics is a psychedelic drug development company.Diamond Therapeutics is a psychedelic drug development company based in Toronto. โ€ฆSee details»

Diamond Therapeutics โ€” New Index

To learn more about Diamond, visit us at www.diamondthera.com. About Ontario Brain Institute The Ontario Brain Institute is a not-for-profit organization that accelerates discovery and โ€ฆSee details»

Diamond Therapeutics

Diamond Therapeutics est une société pharmaceutique psychédélique. Nous développons des thérapies sûres, approuvées par la FDA, l'EMA et Santé Canada pour les troubles โ€ฆSee details»

Diamond Therapeutics

Diamond Therapeutics is revolutionizing the treatment of mental health by developing FDA-approved, psilocybin-based therapeutics that deliver patient benefits without undesired โ€ฆSee details»

Diamond Therapeutics Announces Health Canada โ€ฆ

Aug 17, 2021 /CNW/ - Diamond Therapeutics Inc. ("Diamond"), a drug development company focused on low-dose psychedelic therapies for use in the treatment of mental health,...See details»

Diamond Therapeutics - Psychedelic Science Review

Founded in 2018, Diamond Therapeutics is a psychedelic pharmaceutical company based in Toronto, Canada. Its initial focus is to develop rapid-acting, โ€œsub-perceptualโ€ psilocybin-based โ€ฆSee details»

Diamond Therapeutics - LifeScienceHistory.com

Diamond Therapeutics is a clinical-stage drug development company founded to develop new and better therapies for mental health conditions by unlocking the promise of psychedelic compounds.See details»

Building innovation in brain research & care | Ontario Brain Institute

Jan 7, 2021 To learn more about Diamond, visit us at www.diamondthera.com. About Ontario Brain Institute The Ontario Brain Institute is a not-for-profit organization that accelerates โ€ฆSee details»

Diamond Therapeutics Announces First Patient โ€ฆ

Oct 17, 2023 /CNW/ - Diamond Therapeutics Inc. ("Diamond"), a clinical-stage drug development company focused on non-hallucinogenic, psychedelic-based therapies for use in...See details»

Ontario Brain Institute Increases Investment in Diamond โ€ฆ

To learn more about Diamond, visit us at www.diamondthera.com. About Ontario Brain Institute The Ontario Brain Institute is a not-for-profit organization that accelerates discovery and โ€ฆSee details»

Ontario Brain Institute Increases Investment in Diamond

Jan 7, 2021 About Ontario Brain Institute The Ontario Brain Institute is a not-for-profit organization that accelerates discovery and innovation, benefiting both patients and the โ€ฆSee details»

Diamond Therapeutics Signs Agreement with McGill University for ...

Feb 4, 2021 To learn more about Diamond, visit www.diamondthera.com. About McGill University Founded in Montreal, Quebec, in 1821, McGill is a leading Canadian post โ€ฆSee details»

Diamond Therapeutics - neuly.com

A privately held company Cambridge, Massachusetts, USA https://www.diamondthera.com Development ResearchSee details»

Overview, News & Similar companies - ZoomInfo.com

Apr 4, 2023 View Diamond Therapeutics (www.diamondthera.com) location in Ontario, Canada , revenue, industry and description. Find related and similar companies as well as employees โ€ฆSee details»

Diamond Therapeutics initiates dosing in first-ever Phase 2a โ€ฆ

Jul 30, 2025 Diamondโ€™s focus is on safe, effective treatments suitable for broad patient populations. Learn more at: www.diamondthera.com About KHSC-RI Kingston Health โ€ฆSee details»

Diamond Therapeutics - LinkedIn

Diamond Therapeutics | 1,187 followers on LinkedIn. Revolutionizing the treatment of mental health | The promise of a new and better class of mental health therapies lies within the โ€ฆSee details»

Diamond Therapeutics completes Phase I clinical study of low โ€ฆ

Dec 12, 2022 The trial is the first to identify a safe, active, non-psychedelic dosage of psilocybin. TORONTO, Dec. 7, 2022 /PRNewswire/ โ€“ Diamond Therapeutics Inc. (โ€œDiamondโ€), a drug โ€ฆSee details»

Diamond Therapeutics Overview | SignalHire Company Profile

Diamond Therapeutics is a private company that has been in the industry for 15 years. The company currently specializes in the Pharmaceuticals area. The position of the Founder & โ€ฆSee details»

Diamond Therapeutics 2025 Company Profile: Valuation, Funding ...

Information on valuation, funding, cap tables, investors, and executives for Diamond Therapeutics. Use the PitchBook Platform to explore the full profile.See details»

linkstock.net © 2022. All rights reserved